Stockreport

Sanofi's genetic disorder drug shows mixed results in late-stage trials [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF promise in a late-stage study of patients with ?a type of Gaucher disease, but failed to meet the main goal in ?a separate trial. The oral drug, venglustat, was being [Read more]